Bora TETİK, Gulsum Hilal DEMİ R, Osman KURT, Serdar DERYA

Post-Covid pain frequency and affecting factors

Covid-19 disease was believed to be a short-term disease. However, as the disease was continuing to spread, it was understood that, it can continue for a long time. The aim of this study is to determine the symptoms of individuals with Coronavirus disease 2019 (Covid-19) and those who recovered from the disease and whether they have ongoing symptoms after recovery and the factors affecting of their pain complaints. This descriptive study included 152 patients who admitted to our hospital and diagnosed with Covid-19 and those recovered. The patients were interviewed by telephone and were questioned about their symptoms and conditions when they had Covid-19 and after recovering from Covid-19, by questions based on the literature as well as sociodemographic characteristics. The mean age of the patients was 44.9±13 (min=20, maks=83) and 66 (43.4%) were female and 86 (56.6%) were male. It was determined that 43 patients (28.3%) had and recovered from Covid-19, 1-2 months ago, 60 (39.5%) 2-3 months ago, 36 (23.7%) 3-4 months ago, and 13 (8.8%) 4-5 months ago. During the Covid-19 disease period, pain conditions were listed as 112 had body pain, 94 had headache, 36 had back pain, 35 had joint pain and 13 had lumbar pain. Post-Covid pain was detected in 12 people (7.9%). Body pain was reported in 5 people, headache in 2 people, lumbar pain in 4 people, and both body and joint pain in 1 person. It was observed that as the age group increased, the incidence of post- Covid pain increased. It was determined that the post-Covid pain rate was 7.9% and the patients experienced long-term body, head, lumbar and joint pain. Post-covid pain syndrome was more common in older ages. We suggest that a follow-up algorithm for post-recovery period should be developed.

PDF

___

1. Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265-9.

2. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19-11 March 2020. https://www.who. int/director-general/speeches/detail/who-director-general-s-openingremarks- at-the-media-briefing-on-covid-19---11-march-2020 (access date: 20.03.2021).

3. Demirbilek Y, Pehlivanturk G, Ozguler ZO et al. COVID-19 outbreak control, example of theministry of health of Turkey. Turk J Med Sci. 2020;50(SI-1):489-94.

4. Yang J,Zheng YA, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and metaanalysis. Int J InfectDis. 2020;94:91-5.

5. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683-90.

6. Callard F, Perego E. How and why patients made long covid. Soc Sci Med. 2020;268:113426.

7. Baig AM. Chronic Covid syndrome: needfor an appropriate medical terminology for long‐ Covid and Covid long‐haulers. J Med Virol. 2021 93:2555-6.

8. Greenhalgh T, Knight M, A’Court C, et al. Management of post-acute covid-19 in primary care. BMJ. 2020 11;370:m3026.

9. Parlak S, Beşler MS, Özkaya UE. Relationship between the chest CT characteristics and clinical outcomes of Covid-19 patients by age groups, Ankara Med J, 2020;4:1061-70.

10. Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;22:369:m1966.

11. Guan WJ, Liang WH, Zhao Y, et al. China medical treatment expert group for Covid-19(2020). Comorbidity and its impact on 1590 patients with Covid-19 in China: a nation wide analysis. EurRespir J. 2020; 55:2000547.

12. Suleyman G, Fadel RA, Malette KM, et al. Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan detroit. JAMA Netw Open. 2020;3:e2012270.

13. Su S, Cui H, Wang T, et al. Pain: a potentialnewlabel of COVID-19. Brain BehavImmun. 2020;87:159–160.

14. Abdullahi A, Candan SA, Abba MA, et al. Neurological and musculoskeletal features of COVID-19: a systematic review and meta-analysis. Front Neurol. 2020;11:687.

15. Qu G, Chen J, Huang G, et al. A quantitative exploration of symptoms in COVID-19 patients: an observational cohort study. Int J MedSci. 2021;18:1082-95.

16. Murat S, Dogruoz Karatekin B, et al. Clinical presentations of pain in patients with COVID-19 infection. Ir J Med Sci. 2020;1-5.

17. Trigo J, García-Azorín D, Planchuelo-Gómez Á, et al. Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study. J Headache Pain. 2020;21:94.

18. Erbay A. Long COVID: A New Definition. Bozok Med J. 2020;10:111-4.

19. Sahin T, Ayyildiz A, Gencer-Atalay K, et al. Pain symptoms in COVID-19. Am J Phys Med Rehabil. 2021;100:307-12.